跳至主要内容
临床试验/ISRCTN28445844
ISRCTN28445844已完成不适用

A study comparing the effect of various schedules of the 7-valent licensed CRM197 - conjugated pneumococcal vaccine (Prevnar®) on carriage of Streptococcus pneumoniae in infants and toddlers

Individual Sponsor (Israel)0 个研究点目标入组 730 人开始时间: 2005年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
730

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Groups A, B, C, D: 2 m +/- 3 weeks
  • Group E: 18 m +/- 1 m
  • 2. Males or females
  • 3. On time for routine immunization
  • 4. For group E: Received previously 4 doses of Diphtheria, Tetanus, Pertussis (DTP), Haemophilus influenzae type b (Hib) and inactivated polio vaccine (IPV)
  • 5. The parents and legal guardians must understand and be able, willing and likely to fully comply with the study procedures and restrictions
  • 6. The parents and legal guardians must provide written informed consent
  • 7. Patient must be healthy during vaccination procedure

排除标准

  • 1. Prematurity of less than 35 weeks
  • 2. Acute disease at the time of enrollment. Acute disease is defined as the presence of a moderate or severe illness with or without a fever. Study vaccines can be administered to persons with a minor illness such as diarrhea or mild upper respiratory infection (URI) without fever (rectal temperature <38.0 °C/100.4 °F).
  • 3. Axillary temperature >38.0 °C/100.4 °F prior to any injection
  • 4. Any clinically important congenital abnormality, any inherited disorder of the metabolism
  • 5. Thrombocytonpenia or any coagulation disorder that would contraindicate intramuscular (im) injection
  • 6. Prior receipt of a licensed or investigational pneumococcal vaccine
  • 7. Chronic (defined as more than 14 consecutive days) use of immunosuppressants or other immune-modifying drugs. For corticosteroids, this is defined as daily systemic therapy with prednisone or its equivalent at a dose of =2 mg/day.
  • 8. Known or suspected allergy to any constituent of either product administered in the study
  • 9. Known or suspected intolerance of hypersensitivity, to the study materials (or closely related compounds) or any of the stated ingredients, including diphtheria toxoid and tetanus toxoid
  • 10. Hypotonic-hyporesponsive state within 48 hours after a prior dose of any vaccine
  • 11. Persistent inconsolable crying lasting =3 hours within 48 hours after a prior dose of any vaccine
  • 12. Known to be infected with human immunodeficiency virus (HIV) or mother is HIV positive
  • 13. Any other condition or social circumstance (e.g. lack of a telephone, impending relocation) that, in the opinion of the investigator, would make the subject unsuitable or unable to complete the study

研究者

发起方
Individual Sponsor (Israel)

相似试验